Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,055,570 papers from all fields of science
Search
Sign In
Create Free Account
AM 36
Known as:
AM-36
, AM36 compound
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
CNSB 002
Broader (1)
Piperazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Pharmacokinetics and brain uptake of AM‐36, a novel neuroprotective agent, following intravenous administration to rats
J. Nicolazzo
,
T. Nguyen
,
+5 authors
S. Charman
The Journal of pharmacy and pharmacology
2008
Corpus ID: 20226660
The plasma pharmacokinetics and brain uptake of the novel neuroprotective agent AM‐36 (1‐(2‐(4‐chlorophenyl)‐2‐hydroxy)ethyl‐4‐(3…
Expand
2006
2006
AM‐36 modulates the neutrophil inflammatory response and reduces breakdown of the blood brain barrier after endothelin‐1 induced focal brain ischaemia
R. M. Weston
,
B. Jarrott
,
Y. Ishizuka
,
J. Callaway
British Journal of Pharmacology
2006
Corpus ID: 32653239
Following transient focal stroke, rapid accumulation and activation of neutrophils in the ischaemic region is deleterious due to…
Expand
2004
2004
Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence
J. Callaway
,
J. Callaway
,
+7 authors
B. Jarrott
Neuropharmacology
2004
Corpus ID: 23419900
2003
2003
AM-36, a novel neuroprotective agent, profoundly reduces reactive oxygen species formation and dopamine release in the striatum of conscious rats after endothelin-1-induced middle cerebral artery…
J. Callaway
,
A. Lawrence
,
B. Jarrott
Neuropharmacology
2003
Corpus ID: 5553880
2001
2001
Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM‐36, results in profound inhibition of neuronal apoptosis
J. Callaway
,
P. Beart
,
B. Jarrott
,
S. Giardina
British Journal of Pharmacology
2001
Corpus ID: 28151724
AM‐36 is a novel neuroprotective agent incorporating both antioxidant and Na+ channel blocking actions. In cerebral ischaemia…
Expand
2001
2001
Investigation of AM-36: a novel neuroprotective agent.
Callaway Jk
2001
Corpus ID: 71468819
SUMMARY 1. The neurochemical sequelae following cerebral ischaemia are complex, involving excess release of excitatory amino…
Expand
Review
2001
Review
2001
Investigation Of AM‐36: A Novel Neuroprotective Agent
J. Callaway
Clinical and Experimental Pharmacology and…
2001
Corpus ID: 32618945
1. The neurochemical sequelae following cerebral ischaemia are complex, involving excess release of excitatory amino acids…
Expand
2000
2000
A novel, rapid, computerised method for quantitation of neuronal damage in a rat model of stroke
J. Callaway
,
Melissa Knight
,
Dianne Watkins
,
P. Beart
,
Bevyn Jarrott
,
Peter M Delaney
Journal of Neuroscience Methods
2000
Corpus ID: 42266653
Highly Cited
1999
Highly Cited
1999
Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.
J. Callaway
,
M. J. Knight
,
D. Watkins
,
P. Beart
,
B. Jarrott
Stroke
1999
Corpus ID: 36563737
BACKGROUND AND PURPOSE AM-36 is a novel arylalkylpiperazine with combined antioxidant and Na(+) channel blocking actions…
Expand
1948
1948
New North American chiggers, Acarina, Trombiculidae.
J. Brennan
Journal of Parasitology
1948
Corpus ID: 39248947
Larvae, in life, orange, broad-elliptical. Size: Length, 500 to 643; width, 316 to 408. Capitulum (Fig. 1, B): Chelicerae…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required